Alkermes plc | Mid-cap | Healthcare
$28.61
-0.69%
| Alkermes plc Stock Comparison:
Alkermes plc vs ZoetisAlkermes plc vs Haleon Plc - ADRAlkermes plc vs Regencell BioscienceAlkermes plc vs Elanco Animal HealthAlkermes plc vs Lantheus HoldingsAlkermes plc vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.6B
Gross Profit 1.3B 84.25%
Operating Income 420.6M 27.00%
Net Income 367.1M 23.57%
EPS (Diluted) $2.17

Balance Sheet Metrics

Total Assets 2.1B
Total Liabilities 590.6M
Shareholders Equity 1.5B
Debt to Equity 0.40

Cash Flow Metrics

Operating Cash Flow 428.1M
Free Cash Flow 405.6M

Revenue & Profitability Trend

Alkermes plc Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 1.6B 1.7B 1.1B 1.2B 1.0B
Cost of Goods Sold 245.3M 253.0M 218.1M 197.3M 178.3M
Gross Profit 1.3B 1.4B 893.7M 976.4M 860.4M
Operating Expenses 890.6M 960.6M 863.5M 840.5M 933.4M
Operating Income 420.6M 414.1M -6.1M 97.7M -112.4M
Pre-tax Income 443.8M 421.5M -31.1M 87.7M -96.5M
Income Tax 71.6M -97.6M 2.0M 11.3M 14.3M
Net Income 367.1M 355.8M -158.3M -48.2M -110.9M
EPS (Diluted) $2.17 $2.10 -$0.97 -$0.30 -$0.70

Income Statement Trend

Alkermes plc Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 1.4B 1.5B 1.1B 1.1B 1.1B
Non-Current Assets 640.2M 650.7M 833.7M 962.3M 838.8M
Total Assets 2.1B 2.1B 2.0B 2.0B 1.9B
Liabilities
Current Liabilities 465.2M 520.2M 497.7M 471.3M 438.3M
Non-Current Liabilities 125.4M 413.3M 422.5M 440.6M 444.5M
Total Liabilities 590.6M 933.5M 920.2M 911.9M 882.7M
Equity
Total Shareholders Equity 1.5B 1.2B 1.0B 1.1B 1.1B

Balance Sheet Composition

Alkermes plc Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 367.1M 355.8M -158.3M -48.2M -110.9M
Operating Cash Flow 428.1M 424.7M 11.5M 78.7M 28.2M
Investing Activities
Capital Expenditures -33.0M -47.7M -38.3M -27.7M -41.6M
Investing Cash Flow -111.3M 53.4M -63.3M -57.3M -7.6M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -521.7M -306.5M -21.2M 3.8M -10.5M
Free Cash Flow 405.6M 353.3M -17.2M 72.7M 40.6M

Cash Flow Trend

Alkermes plc Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 13.93
Forward P/E 14.56
Price to Book 3.19
Price to Sales 3.19
PEG Ratio 14.56

Profitability Ratios

Profit Margin 23.30%
Operating Margin 4.50%
Return on Equity 25.71%
Return on Assets 11.62%

Financial Health

Current Ratio 3.33
Debt to Equity 4.90
Beta 0.42

Per Share Data

EPS (TTM) $2.10
Book Value per Share $9.17
Revenue per Share $9.22

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
alks 4.8B 13.93 3.19 25.71% 23.30% 4.90
Zoetis 70.3B 28.34 15.12 52.09% 27.12% 145.63
Haleon Plc - ADR 47.2B 25.01 5.88 8.95% 12.84% 63.41
Regencell Bioscience 18.5B - 1,394.12 -43.18% 0.00% 1.04
Elanco Animal Health 6.6B 17.80 1.04 6.01% 8.43% 69.18
Lantheus Holdings 5.6B 23.07 4.81 24.11% 16.55% 52.78

Financial data is updated regularly. All figures are in the company's reporting currency.